The global multiple myeloma treatment market is witnessing a period of remarkable growth. This growth can be connected to a number of factors, including an increasing population, augmenting incidence rates of the disease, and progresses in treatment options. Key stakeholders in this market are focused on developing cutting-edge therapies to improve